Cleveland Clinic and IBM researchers are using quantum computing to tackle one of the most challenging problems in immuno-oncology: predicting which tumor mutations will trigger an immune response.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗